- Home
- GRAL vs EBS Comparison
GRAL vs EBS Comparison
Compare GRAL & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRAL
- EBS
- Stock Information
- Founded
- GRAL 2016
- EBS 1998
- Country
- GRAL United States
- EBS United States
- Employees
- GRAL N/A
- EBS N/A
- Industry
- GRAL
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- GRAL
- EBS Health Care
- Exchange
- GRAL NYSE
- EBS Nasdaq
- Market Cap
- GRAL 610.9M
- EBS 518.0M
- IPO Year
- GRAL N/A
- EBS 2006
- Fundamental
- Price
- GRAL $18.49
- EBS $10.20
- Analyst Decision
- GRAL Hold
- EBS Strong Buy
- Analyst Count
- GRAL 2
- EBS 3
- Target Price
- GRAL $16.00
- EBS $14.33
- AVG Volume (30 Days)
- GRAL 967.8K
- EBS 1.1M
- Earning Date
- GRAL 02-15-2025
- EBS 03-04-2025
- Dividend Yield
- GRAL N/A
- EBS N/A
- EPS Growth
- GRAL N/A
- EBS N/A
- EPS
- GRAL N/A
- EBS N/A
- Revenue
- GRAL $117,669,000.00
- EBS $1,125,500,000.00
- Revenue This Year
- GRAL $32.48
- EBS $6.26
- Revenue Next Year
- GRAL $14.72
- EBS $2.42
- P/E Ratio
- GRAL N/A
- EBS N/A
- Revenue Growth
- GRAL 111.83
- EBS 2.05
- 52 Week Low
- GRAL $12.33
- EBS $1.42
- 52 Week High
- GRAL $24.92
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- GRAL N/A
- EBS 60.60
- Support Level
- GRAL N/A
- EBS $9.20
- Resistance Level
- GRAL N/A
- EBS $10.63
- Average True Range (ATR)
- GRAL 0.00
- EBS 0.67
- MACD
- GRAL 0.00
- EBS 0.05
- Stochastic Oscillator
- GRAL 0.00
- EBS 81.86
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.